Top

Published in:

01-06-2012 | Editorial

Ovarian cancer and the pelvic floor surgeon: the case for prophylactic bilateral salpingectomy during POP surgery

Author: Peter L. Dwyer

Published in: International Urogynecology Journal | Issue 6/2012

Excerpt

Ovarian cancer is a leading cause of cancer death in women and has a high mortality rate and a low 5-year survival rate (around 30%). Presentation is typically with late-stage metastatic disease which responds poorly to the conventional treatment of surgery and chemotherapy; most cancer deaths occur in women with high-grade serous ovarian carcinoma [1]. Screening tests employed before symptoms develop using either measurement of CA125 levels, ultrasound, or both have as yet not been proved effective in early detection. Despite extensive research the incidence of ovarian cancer is increasing and the survival rates have not improved significantly over the past decade [1]. …

Piver MS (1996) Prophylactic oophorectomy: reducing the U.S. death rate from epithelial ovarian cancer. A continuing debate. Oncologist 1(5):326–330PubMed

Brown JS, Waetjen LE, Subak LL, Thom DH, Van den Eeden S, Vittinghoff E (2002) Pelvic organ prolapse surgery in the United States, 1997. Am J Obstet Gynecol 186(4):712–716PubMedCrossRef

Asante A, Whiteman MK, Kulkarni A, Cox S, Marchbanks PA, Jamieson DJ (2010) Elective oophorectomy in the United States: trends and in-hospital complications, 1998–2006. Obstet Gynecol 116(5):1088–1095PubMedCrossRef

Brand A (2011) The RANZCOG College Statement on prophylactic oophorectomy in older women undergoing hysterectomy for benign disease: is the evidence sufficient to change practice? Aust N Z J Obstet Gynaecol 51(4):296–300PubMedCrossRef

Olive DL (2005) Dogma, skepsis, and the analytic method; the role of prophylactic oophorectomy at the time of hysterectomy. Obstet Gynecol 106:214–215PubMedCrossRef

Shuster LT, Gostout BS, Grossard BD, Rocca WA (2008) Propylactic oophorectomy in pre-menopausal women and longterm health—a review. Menopause Int 14(3):111–116PubMedCrossRef

Crum CP, Drapkin R, Kindelberger D, Medeiros F, Miron A, Lee Y (2007) Lessons from BRCA: the tubal fimbria emerges as an origin for pelvic serous cancer. Clin Med Res 5(1):35–44PubMedCrossRef

Kindelberger DW, Lee Y, Miron A, Hirsch MS, Feltmate C, Medeiros F, Callahan MJ, Garner EO, Gordon RW, Birch C, Berkowitz RS, Muto MG, Crum CP (2007) Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: evidence for a causal relationship. Am J Surg Pathol 31(2):161–169PubMedCrossRef

Przybycin CG, Kurman RJ, Ronnett BM, Shih IeM, Vang R (2010) Are all pelvic (nonuterine) serous carcinomas of tubal origin? Am J Surg Pathol 34(10):1407–1416PubMedCrossRef

Title: Ovarian cancer and the pelvic floor surgeon: the case for prophylactic bilateral salpingectomy during POP surgery
Author: Peter L. Dwyer
Publication date: 01-06-2012
Publisher: Springer-Verlag
Published in: International Urogynecology Journal / Issue 6/2012
Print ISSN: 0937-3462
Electronic ISSN: 1433-3023
DOI: https://doi.org/10.1007/s00192-012-1727-x

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Ovarian cancer and the pelvic floor surgeon: the case for prophylactic bilateral salpingectomy during POP surgery

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 6/2012

New approach in vaginal prolapse repair: mini-invasive surgery associated with application of platelet-rich fibrin

Anterior colporrhaphy does not induce bladder outlet obstruction

The results of a 24-h pad test in Brazilian women

Predicting anal sphincter defects: the value of clinical examination and manometry

Polypropylene mesh and the host response

Successful management of a thick transverse vaginal septum with a vesicovaginal fistula by vaginal expansion and surgery